Drug profile · INN
methylene blue
METHYLENE BLUE
methylene blue (METHYLENE BLUE) is a reducing agent. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 1
Pipeline programs 2
News articles 0
Drug details — methylene blue
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 1
- Programs
- 2
- Data quality
- 0.84
Quick answer
methylene blue (METHYLENE BLUE) is a reducing agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN methylene blue
Brand METHYLENE BLUE
Mechanism Reducing agent
Route INTRAVENOUS
Formulation SOLUTION
Mechanism of action
Reducing agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is methylene blue?
methylene blue (METHYLENE BLUE) is a reducing agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for methylene blue?
METHYLENE BLUE is a marketed brand name for methylene blue. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methylene blue?
methylene blue has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.